Health Care & Life Sciences » Pharmaceuticals | Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc. | Ownership

Companies that own Amphastar Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
5,413,475
11.7%
285,598
0.01%
06/30/2018
The Vanguard Group, Inc.
2,219,211
4.8%
-41,499
0%
06/30/2018
Dimensional Fund Advisors LP
1,769,533
3.83%
84,085
0.01%
06/30/2018
Federated Global Investment Management Corp.
1,276,552
2.76%
227,142
0.17%
06/30/2018
SSgA Funds Management, Inc.
1,005,888
2.17%
18,004
0%
06/30/2018
Teachers Advisors LLC
562,790
1.22%
12,760
0.01%
06/30/2018
Northern Trust Investments, Inc.
456,862
0.99%
-10,493
0%
06/30/2018
Cortina Asset Management LLC
392,296
0.85%
130,604
0.32%
06/30/2018
Geode Capital Management LLC
380,859
0.82%
39,393
0%
06/30/2018
Rothschild Asset Management, Inc.
328,841
0.71%
13,157
0.06%
06/30/2018

About Amphastar Pharmaceuticals

View Profile
Address
11570 6th Street
Rancho Cucamonga California 91730
United States
Employees -
Website http://www.amphastar.com
Updated 07/08/2019
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.